JSA advised ICICI Securities Limited, Nuvama Wealth Management Limitedand SBI Capital Markets Limited in relation to the initial public offering of equity shares of Suraksha Diagnostic Limited aggregating to ₹8,462.49 million (“IPO”), comprising of an offer for sale by OrbiMed Asia II Mauritius Limited, Dr. Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma, Munna Lal Kejriwal and Santosh Kumar Kejriwal.
Suraksha Diagnostic Limited offers one-stop integrated solutions for pathology and radiology testing and medical consultation services through their operational network consisting of a central reference laboratory, satellite laboratories, diagnostic centres, and sample collection centres.
Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Pracheta Bhattacharya, Senior Associate – Sourav Modi, and Associates – Dhvanit Kothari, Jeebitesh Bhattacharya, Ankesh Kumar, and Junior Associate – Anoop Mukundan.
Arka Mookerjee is a Partner and Co-Head of the Equity Capital Markets practice, with over 21 years of experience advising on India’s most complex and high-value transactions. Widely recognised for pioneering mandates—including India’s first QIP and InvIT IPO—he represents issuers, underwriters and investors across capital markets and investment structures. Arka actively engages with regulators and industry bodies, playing a key role in shaping India’s evolving capital markets framework.